MEDIUM confidence: 100% data completeness, but the composite (65) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Avg target $109 (last qtr, 8 analysts) → $114 (last mo, 6) (+4.4%).
Buy-rated share 43% → 38% over ~3 months (-5pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Apr 2026 | $1.38 | $1.81 | +31.2% |
| Feb 2026 | $1.90 | $1.80 | -5.3% |
| Oct 2025 | $1.66 | $2.26 | +36.1% |
| Jul 2025 | $1.39 | $1.57 | +12.9% |
| Apr 2025 | $1.01 | $1.16 | +14.9% |
| Feb 2025 | $1.57 | $1.43 | -8.9% |
| Oct 2024 | $1.12 | $1.07 | -4.5% |
| Jul 2024 | $0.78 | $-1.82 | -333.3% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.0B— | $3.4B+13.7% | $3.7B+8.9% | $4.2B+14.8% | $5.1B+21.2% |
| EPS (dil.) | $4.27— | $1.52-64.4% | $2.65+74.3% | $0.15-94.3% | $6.41+4173.3% |
| Free Cash Flow | $568M— | $892M+56.9% | $449M-49.7% | $249M-44.5% | $1.4B+443.9% |
| Gross Margin | 94.9% | 93.9%-1.0pp | 93.1%-0.8pp | 92.6%-0.5pp | 92.8%+0.1pp |
| Operating Margin | 19.6% | 17.4%-2.2pp | 17.7%+0.3pp | 2.4%-15.3pp | 26.1%+23.7pp |
| Net Margin | 31.8% | 10.0%-21.7pp | 16.2%+6.1pp | 0.8%-15.4pp | 25.0%+24.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net insider -$10.1M over 180 days (0 open-market buys, 8 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Incyte Corporation's QScore of 65 indicates a relatively strong stock, driven by high growth scores, with revenue and EPS growth of 21.2% and 4018.8%, respectively. The stock's momentum also scores high, with a 12-month return of 68.4% and a bullish 50-day versus 200-day moving average. However, the value score is lower, reflecting a P/E of 15.6 and EV/EBITDA of 10.3, which is somewhat offset by strong profitability, with an ROE of 29.3%. The long-term and short-term scores are relatively aligned, with only a 2-point difference.